Skip to content

Switzerland English logo

Main menu
    • About us
    • Our vision
    • Our values
    • Environmental, Social & Governance (ESG)
    • Organon GmbH – Transparenz
  • Our areas of focus
  • Media/Press
  • Join our team
  • Contact Us

Back
Change Language
  • Contact Us
  • Deutsch
  • Français
Main menu

Organon site directory

  • Organon

    • Brazil
    • Canada  English  ·  French
    • Latin America
    • Mexico
    • USA
  • Organon

    • Austria
    • Belgium  Dutch  ·  English  ·  French
    • Bulgaria
    • Czech Republic
    • Denmark
    • Estonia
    • Finland
    • France
    • Germany
    • Hungary
    • Ireland
    • Italy
    • Latvia
    • Lithuania
    • Luxembourg  English  ·  French
    • Netherlands  Dutch  ·  English
    • Norway
    • Poland
    • Portugal
    • Romania
    • Russia
    • Serbia
    • Slovakia
    • Slovenia
    • Spain
    • Sweden
    • Switzerland  French  ·  German  ·  English
    • Ukraine  Ukrainian  · 
    • United Kingdom
  • Organon

    • Australia
    • Hong Kong, China
    • Indonesia
    • Japan
    • Malaysia
    • New Zealand
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Organon

    • Egypt
    • Israel
    • Jordan
    • KSA
    • Kuwait
    • Lebanon
    • Northwest Africa  French  ·  Arabic  ·  Turkey
    • Oman
    • South Africa
    • Turkey
    • UAE
View all locations and contact information

What can we help you find?

Search for:

Environmental, Social & Governance (ESG)

Read the 2022 Organon & Co. CSR report (June 2023) Opens a new window

Her Promise, Our Purpose

Our purpose is to help women and girls achieve their promise through better health and is inextricably linked to our company vision: to create a better and healthier every day for every woman around the world. By addressing gender-related disparities in health, we build a more sustainable future for women, families, economies and society. Our environmental, social and governance goals focus on three areas: Her Equity, Her Planet, and Her Trust, and the issues that matter most to our stakeholders, our business, and most importantly, women around the world.

Our environmental, social and governance objectives are focused on three areas:

Illustration of back of woman with flowers in hair against grey background representing the social aspect of the ESG platform

Her equity :

Throughout the world, women have vast unmet medical needs. Our goal is to redefine and harness innovation to help women and girls achieve their promise and lead healthier, more empowered lives.

Illustration of woman cradling globe with scene of stream and mountains representing the environmental aspects of the ESG framework

Her planet :

Women are disproportionately affected by the impact of climate change. They are also more vulnerable to resource scarcity, which is why a healthy planet is important to helping women and girls achieve their promise.

Illustration of two rows of women of diverse cultural backgrounds facing each other on beige background representing ESG policy

Her trust :

To fulfill her promise, we are working to promote balanced gender representation at all levels. We aim to reflect the gender equity within our company that we want to see in the world.

Organon strives to :

– Develop access to medicines and healthcare
– Invest in women’s health innovations
– Support diversity, equity, inclusion and belonging
– Implement virtuous environmental management

Social responsibility: unwanted pregnancies

Provide 100 million teenage girls and women in low- or moderate-income countries with affordable access to options for contraception by 2030.

Social responsibility: innovation

Our goal is to redefine and harness innovation in women’s health by dedicating the majority of our preclinical and clinical development activities to areas that address the unmet health needs of women.

Social responsibility: access

Expanding access to treatment options that support the health of everyone.

Governance: gender parity and pay equality

Achieving pay equality and balanced gender representation at all levels of our company globally by 2030.

Governance: ethics and integrity

Upholding the highest standards of ethics and integrity in all our activities.

Environment: carbon emissions

Supporting the transition to a low-carbon economy, with the ambition of achieving net-zero greenhouse gas emissions.

Environment: water and waste

Integrating responsible water management principles and circular economy practices into our business model by 2050. Developing and implementing sustainable packaging guidelines for all our products. Optimizing waste sorting and recycling while reducing overall waste production.

Environment: responsible procurement

Promoting partnerships that support our ESG commitments in ethical, societal, and environmental areas. Continuing a responsible sourcing strategy by assessing the carbon impact of our entire value chain, including the activities of our suppliers and partners.

https://www.organon.com/france/wp-content/uploads/sites/6/2022/05/unplanned-pregnancy-sm.png
Groupe unis de collaborateurs

Increase access to family planning options in the world

With our initiative Her Promise Access, we work with organizations all over the world to educate, train and provide access to contraceptive options in 69 less developed countries in the world.

We support the United Nations sustainable development objectives

Organon supports the United Nations sustainable development objectives and participates in the United Nations Global Pact. Our desire is to integrate the principles of water management, as defined in the United Nations Global Pact CEO Water Mandate, into our business models.

About Organon

About us

CH-NON-110142 – June 2025

Switzerland English logo
  • Publisher
  • Terms of Use
  • AGB
  • Cookie Policy
  • Privacy Policy
© 2025 Organon group of companies. All rights reserved.

You are leaving Organon.com

Cancel Continue Opens a new window

Forward-looking statement of Organon

This news release of Organon (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. There can be no guarantees with respect to pipeline products that the products will receive the necessary regulatory approvals or that they will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.

Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of the recent global outbreak of novel coronavirus disease (COVID-19); the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.

The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s 2020 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov Opens a new window ).

No Duty to Update

The information contained in this website was current as of the date presented. The company assumes no duty to update the information to reflect subsequent developments. Consequently, the company will not update the information contained in the website and investors should not rely upon the information as current or accurate after the presentation date.

Decline Accept